Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin

Published:2015-05 Issue:1 Volume:82 Page:73-77
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Jones Ronald N.,Farrell David J.,Flamm Robert K.,Sader Helio S.,Dunne Michael W.,Mendes Rodrigo E.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference27 articles.

1. Initial quality control evaluations for susceptibility testing of dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity;Anderegg;J Clin Microbiol,2003

2. In vivo pharmacodynamic activity of the glycopeptide dalbavancin;Andes;Antimicrob Agents Chemother,2007

3. Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates;Biedenbach;Antimicrob Agents Chemother,2009

4. Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic;Billeter;Clin Infect Dis,2008

5. Once-weekly dalbavancin versus daily conventional therapy for skin infection;Boucher;N Engl J Med,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substance use disorder-associated infections’ treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) – an investigator-initiated single-arm unblinded prospective cohort study;Therapeutic Advances in Infectious Disease;2024-01

2. Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin;Expert Review of Anti-infective Therapy;2023-05-31

3. The Role of Novel Antibiotics in the Management of Diabetic Foot Infection;Diabetes Therapy;2022-12-24

4. Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections;Pharmaceutics;2022-09-06

5. New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides;Antimicrobial Agents and Chemotherapy;2022-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3